Business
Currency:USD
2024/FY
Stock NameRevenueRatio
Research and development of innovative drug candidates for the treatment of human cancer10.91M100.00%
Region
Currency:USD
2024/FY
Stock NameRevenueRatio
United States10.91M100.00%